Lipidor AB (publ) announced that the Board of Directors has resolved to postpone the publication of the Annual Report for 2023 to 15 May 2024. The previously communicated date for publication was 24 April 2024. The reason for the postponement is to synchronise the Annual Report work with the work on the Company's forthcoming rights issue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 SEK | -8.09% | -2.26% | -57.14% |
Apr. 22 | Lipidor AB Postpones the Publication of Annual Report for 2023 | CI |
Mar. 21 | Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-57.14% | 636K | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- LIPI Stock
- News Lipidor AB
- Lipidor AB Postpones the Publication of Annual Report for 2023